Chassagne C, Eddahibi S, Adamy C, Rideau D, Marotte F, Dubois-Randé J L, Adnot S, Samuel J L, Teiger E
INSERM U127, Institut Fédératif de Recherche Circulation, Hôpital Lariboisière, Université Denis Diderot, Paris, France.
Am J Respir Cell Mol Biol. 2000 Mar;22(3):323-32. doi: 10.1165/ajrcmb.22.3.3701.
Lung vessel muscularization during hypoxic pulmonary hypertension is associated with local renin-angiotensin system activation. The expression of angiotensin II (Ang II) AT1 and AT2 receptors in this setting is not well known and has never been investigated during normoxia recovery. We determined both chronic hypoxia and normoxia recovery patterns of AT1 and AT2 expression and distal muscularization in the same lungs using in situ binding, reverse transcriptase/polymerase chain reaction, and histology. We also used an isolated perfused lung system to evaluate the vasotonic effects of AT1 and AT2 during chronic exposure to hypoxia with and without subsequent normoxia recovery. Hypoxia produced right ventricular hypertrophy of about 100% after 3 wk, which reversed with normoxia recovery. Hypoxia for 2 wk was associated with simultaneous increases (P<0.05) in AT1 and AT2 binding (16-fold and 18-fold, respectively) and in muscularized vessels in alveolar ducts (2. 8-fold) and walls (3.7-fold). An increase in AT2 messenger RNA (mRNA) (P<0.05) was also observed, whereas AT1 mRNA remained unchanged. After 3 wk of hypoxia, muscularization was at its peak, whereas all receptors and transcripts showed decreases (P<0.05 versus hypoxia 2 wk for AT1 mRNA), which became significant after 1 wk of normoxia recovery (P<0.05 versus hypoxia 2 wk). Significant reversal of muscularization (P<0.01) was found only after 3 wk of normoxia recovery in alveolar wall vessels. Finally, the AT1 antagonist losartan completely inhibited the vasopressor effect of Ang II in hypoxic and normoxia-restored lungs, whereas the AT2 agonist CGP42112A had no effect. Our data indicate that in lungs, chronic hypoxia-induced distal muscularization is associated with early and transient increases in AT2 and AT1 receptors probably owing to hypoxia- dependent transcriptional and post-transcriptional regulatory mechanisms, respectively. They also indicate that the vasotonic response to Ang II is mainly due to the AT1 subtype.
低氧性肺动脉高压期间肺血管肌化与局部肾素-血管紧张素系统激活有关。在这种情况下,血管紧张素II(Ang II)AT1和AT2受体的表达尚不清楚,且在常氧恢复过程中从未被研究过。我们使用原位结合、逆转录/聚合酶链反应和组织学方法,确定了同一肺中AT1和AT2表达以及远端肌化的慢性低氧和常氧恢复模式。我们还使用离体灌注肺系统,评估了在慢性低氧暴露期间以及随后常氧恢复时AT1和AT2的血管张力作用。低氧3周后导致右心室肥厚约100%,常氧恢复后逆转。低氧2周与AT1和AT2结合(分别增加16倍和18倍)以及肺泡导管(增加2.8倍)和肺泡壁(增加3.7倍)中肌化血管同时增加(P<0.05)有关。还观察到AT2信使核糖核酸(mRNA)增加(P<0.05),而AT1 mRNA保持不变。低氧3周后,肌化达到峰值,而所有受体和转录物均减少(与低氧2周时相比,AT1 mRNA P<0.05),常氧恢复1周后变得显著(与低氧2周时相比P<0.05)。仅在常氧恢复3周后,肺泡壁血管中的肌化才出现显著逆转(P<0.01)。最后,AT1拮抗剂氯沙坦完全抑制了Ang II在低氧和常氧恢复肺中的升压作用,而AT2激动剂CGP42112A则无作用。我们的数据表明,在肺中,慢性低氧诱导的远端肌化与AT2和AT1受体的早期和短暂增加有关,可能分别归因于低氧依赖性转录和转录后调节机制。它们还表明,对Ang II的血管张力反应主要归因于AT1亚型。